mTOR signaling in skeletal development and disease

Area of Science:

• Biochemistry
• Molecular Biology
• Skeletal Biology

Background:

• The mechanistic target of rapamycin (mTOR) is a key kinase regulating cellular processes.
• mTOR signaling, through mTORC1 and mTORC2 complexes, is vital for skeletal development and homeostasis.
• mTORC1 acts as a common pathway for bone-anabolic factors like Igf1, Wnt, and Bmp.

Purpose of the Study:

• To review the role of mTOR signaling in skeletal development, bone homeostasis, and articular cartilage maintenance.
• To explore the potential of targeting mTOR pathways for treating skeletal diseases.

Main Methods:

• Literature review of recent mouse genetic studies.
• Analysis of mTOR pathway involvement in skeletal biology.
• Examination of mTORC1's role as a mediator of bone anabolic effects.

Main Results:

• mTOR pathways are crucial for multiple aspects of skeletal development and homeostasis.
• mTORC1 is an effector for Igf1, Wnt, and Bmp, influencing bone anabolism.
• Dysregulation of mTORC1 is implicated in skeletal diseases such as osteoarthritis and osteoporosis.

Conclusions:

• mTOR signaling is integral to skeletal health and articular cartilage maintenance.
• Targeting mTOR signaling presents a promising therapeutic strategy for skeletal diseases.